• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 84-98 of 133 results

1001 Exhibit: MYLAN EX 1001 US Patent No 9,320,716

Document IPR2017-01034, No. 1001 Exhibit - MYLAN EX 1001 US Patent No 9,320,716 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1006 Exhibit: MYLAN EX 1006 Declaration of Anthony Palmieri III, PhD, RPh

Document IPR2017-01034, No. 1006 Exhibit - MYLAN EX 1006 Declaration of Anthony Palmieri III, PhD, RPh (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1018 Exhibit: MYLAN EX 1018 Campieri et al,

Document IPR2017-01034, No. 1018 Exhibit - MYLAN EX 1018 Campieri et al, (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1015 Exhibit: MYLAN EX 1015 Amendment After Final

Document IPR2017-01034, No. 1015 Exhibit - MYLAN EX 1015 Amendment After Final (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1040 Exhibit: MYLAN EX 1040 US Patent No 5,849,327

Document IPR2017-01034, No. 1040 Exhibit - MYLAN EX 1040 US Patent No 5,849,327 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1007 Exhibit: MYLAN EX 1007 Curricula Vitae of Anthony Palmieri, PhD, RPh

Document IPR2017-01034, No. 1007 Exhibit - MYLAN EX 1007 Curricula Vitae of Anthony Palmieri, PhD, RPh (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1039 Exhibit: MYLAN EX 1039 SS Davis, The Design and Evaluation of Controlled R...

Document IPR2017-01034, No. 1039 Exhibit - MYLAN EX 1039 SS Davis, The Design and Evaluation of Controlled Release Dosage Forms for Oral Delivery (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1014 Exhibit: MYLAN EX 1014 Substitute Specification Clean Copy US Patent Appl...

Document IPR2017-01034, No. 1014 Exhibit - MYLAN EX 1014 Substitute Specification Clean Copy US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1017 Exhibit: MYLAN EX 1017 US Patent No 6,607,751

Document IPR2017-01034, No. 1017 Exhibit - MYLAN EX 1017 US Patent No 6,607,751 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1010 Exhibit: MYLAN EX 1010 US Patent No 6,239,120

Document IPR2017-01034, No. 1010 Exhibit - MYLAN EX 1010 US Patent No 6,239,120 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1002 Exhibit: MYLAN EX 1002 US Patent No 8,784,888

Document IPR2017-01034, No. 1002 Exhibit - MYLAN EX 1002 US Patent No 8,784,888 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1035 Exhibit: MYLAN EX 1035 Flanders et al

Document IPR2017-01034, No. 1035 Exhibit - MYLAN EX 1035 Flanders et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1043 Exhibit: MYLAN EX 1043 Gliko Kabir et al

Document IPR2017-01034, No. 1043 Exhibit - MYLAN EX 1043 Gliko Kabir et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1036 Exhibit: MYLAN EX 1036 Gandhi et al

Document IPR2017-01034, No. 1036 Exhibit - MYLAN EX 1036 Gandhi et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1030 Exhibit: MYLAN EX 1030 Hawley¿¿¿s Condensed Chemical Dictionary

Document IPR2017-01034, No. 1030 Exhibit - MYLAN EX 1030 Hawley¿¿¿s Condensed Chemical Dictionary (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 >>